【ChiCTR2500104800】Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
ChiCTR2500104800
正在进行
/
/
/
2025-06-24
/
/
Cholelithiasis
Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
To compare the outcomes of direct trocar versus Veress needle entry techniques in obese women during laparoscopic cholecystectomy.
随机平行对照
Ⅰ期
The patients will be divided into two equal groups by using lottery method.
Not stated
/
/
90
/
2025-07-01
2026-03-31
/
Obese women with body mass index >= 30 kg/m^2, having cholelithiasis, with an American society of Anesthesiology (ASA) status I and II will be included.;
请登录查看Men, non-obese women, Patients who had previous history of abdominal surgery, ASA status ≥ III, clinically obvious ongoing infection, those having poorly controlled type 2 diabetes mellitus, other comorbid conditions like hypertension and chronic renal failure, concomitant cardiopulmonary severe disease, abnormalities with the clotting/bleeding and the patients who are unfit to undergo general anesthesia.;
请登录查看Combine Military Hospital Quetta
/
Combine Military Hospital Quetta的其他临床试验
Combined Military Hospital Quetta的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构:国家药品监督管理局 2026-09-10
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构:国家市场监督管理总局 2026-09-18
-
颁布机构:国家市场监督管理总局 2026-09-17
-
颁布机构:国家市场监督管理总局 2026-08-10
